As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...

The U.S. House Appropriations committee has passed a bill that would reduce liability for chemical makers whose products have been linked to cancer.

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

Bayer has spent over $200K in Iowa since introducing the contested Cancer Gag Act to shield pesticide corporations from health related lawsuits ...

GERMAN pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

Bayer (BAYRY) stock gains as the company raises 2025 financial outlook, citing strong pharma performance. Read more here.

Bayer has applied for approval in the EU of its new herbicide, icafolin, following applications in Brazil, the US, and Canada ...